ContractEmployment Agreement • March 6th, 2025 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 6th, 2025 Company Industry Jurisdiction
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 11th, 2022 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 11th, 2022 Company Industry JurisdictionThis Amended and Restated Employment Agreement (“Agreement”) is made by and among Xeris Biopharma Holdings, Inc., a Delaware corporation (the “Parent”), Xeris Pharmaceuticals, Inc., a Delaware corporation and wholly-owned subsidiary of the Parent (the “Company”), and Beth P. Hecht (the “Executive”) and is effective as of the closing date of the transactions contemplated by the Transaction Agreement by and among Strongbridge Biopharma plc, the Company and the other parties set forth therein dated May 24, 2021 (the “Effective Date”).